The first self-administered B-cell therapy for patients with relapsing forms of MS

Retrieved on: 2021-04-09 14:34:36

Tags for this article:

Click the tags to see associated articles and topics

The first self-administered B-cell therapy for patients with relapsing forms of MS. View article details on hiswai:

Excerpt

Ofatumumab is a fully human anti-CD20 monoclonal antibody (mAb) ... anti-CD20 monoclonal antibodies and, therefore, may offer flexibility in the ...

Article found on: pharmafield.co.uk